from the world's big
Microdosing magic truffles makes you more creative, new study finds
Is microdosing magic truffles a way to unlock your creative potential? That's long been anecdotal, but the evidence is coming.
- A recent study showed that microdosing magic truffles can significantly increase one's creative thinking.
- Published in Psychopharmacology, the study joins a growing body of research showing the potential benefits of low-dose psychedelics.
- While this research comes with limitations, it could open up many avenues to improve anxiety and work conditions in society.
What is microdosing anyway?
A Dutch smart shop displaying Psilocybe, the genus of magic mushrooms and magic truffles.
(Photo from Wikimedia)
Psychologists James Fadiman and Sophia Korb have compiled more than 1,500 reports detailing individual experiences with microdosing. Based on their research, they define microdosing as when a user takes a small amount of a psychotropic drug, such as LSD, peyote, or magic truffles. A typical microdose lands between one-tenth and one-twentieth of a recreational hit.
As with any drug, effective dosages vary based on the individual's metabolism and tolerance. The microdoser's aim is to take just enough of the substance to heighten mental activity and create a feeling of calm energy, but not enough to hallucinate. If the door's wood grain morphs into a visage of a Gene Wilder-looking mango giving them the double guns, they've overshot the micro mark and adjust the dose.
Most microdosers follow a regiment of one day on, two days off. Others only imbibe when they feel it would be useful for a particular project.
Micro dose, major boost
The study, led by PhD student Luisa Prochazkova under the supervision of Dr. Bernhard Hommel, took place at an event organized by the Psychedelic Society of the Netherlands. Thirty-eight volunteers were asked to perform three tests: a picture concept task, an alternative uses task, and a progressive matrices task.
The picture concept task required participants to find a common association among several objects, while ruling out inappropriate ones. The alternative uses task asked the participants to conceive of as many uses for a common household object as possible within a time limit. Taken together, these two tests measured the participants' convergent and divergent thinking skills, both signs of creativity and elastic thinking.
The progressive matrices task tested the participants' fluid intelligence, which is a person's ability to solve problems with reason and logical thinking.
After the first round of tests, participants were given 0.37 grams of dried magic truffles and repeated another set of tests. The results were significant.
"[O]ur results suggest that consuming a microdose of truffles allowed participants to create more out-of-the-box alternative solutions for a problem, thus providing preliminary support for the assumption that microdosing improves divergent thinking," Prochazkova said in a statement. "Moreover, we also observed an improvement in convergent thinking, that is, increased performance on a task that requires the convergence on one single correct or best solution."
The study showed no significant difference on fluid intelligence.
More mind-bending studies
If your brain reaches this level of creativity, you may have overshot the microdosing mark.
Other tests have shown microdosing psilocybin mushrooms can have other efficacious results.
A study published in The Lancet had participants take psilocybin capsules to combat depression alongside supportive therapy. The participants, who had proven to be treatment resistant beforehand, reported improvement in their symptoms. The researchers expressed hope that psilocybin's chemical structure, which is unique from traditional antidepressants, will open up new avenues for treatment.
A similar study from the University of Zurich found that psilocybin inhibits the brain's limbic system, an area associated with controlling emotions and instinctual urges. By slowing down the amygdala specifically, the drug repressed negative emotions in patients and improved their moods.
Yet another study from Johns Hopkins University suggested that magic truffles could weaken nicotine addiction and help smokers quit.
Tying these studies together is one published in PNAS. It looked at patients high on psilocybin while they were in an fMRI machine. The scans revealed that the compound not only inhibits the limbic system but also the prefrontal cortex and posterior cingulate cortex, areas associated with personality expression, filtering stimuli intake, and intrinsic control.
This proved counter to what many assume is responsible for the magic in the mushrooms—rather than ramping up the brain's activity to 11, psilocybin throttles activity down to a crawl. The disconnection between these specific areas of the brain could explain why psilocybin not only lessens depression but, which taken at a high enough dose, also leads to hallucinations and feelings of oneness with the world.
"The results seem to imply that a lot of brain activity is actually dedicated to keeping the world very stable and ordinary and familiar and unsurprising," Robin Carhart-Harris, the study's lead author, told Time. "It shuts off this ruminating area and allows the mind to work more freely."
Limitations to studying the expanding mind
Microdoses of a magic truffle.
Image: Big Think.
But don't rush out to ask your 16-year-old cousin for his dealer's number. Not just yet.
The Psychopharmacology study lacked several strict experimental controls, making it a preliminary study and far from the final word. It had a small sample size (only 38 participants), provided no control group, did not look for a placebo effect, and neither researchers nor participants were blinded to the use of psilocybin. It is also possible that participants improved simply because they had taken the test beforehand.
The other studies mentioned also lacked these controls, especially with regard to small sample size and not looking at long-term effects.
Of course, the authors of the Psychopharmacology study are upfront about these limitations and recommend future studies have "lab-based randomized double-blind placebo-controlled experimental designs" that take the subjective experience into account.
While these studies suggest magic truffles deliver on their mind-expanding promises, at the moment that remains a suggestion at best. Further and much more rigorous research must be performed before we can say magic truffles can definitively increase creativity and relax our inner critics. Should that day never come, there's always the Overmind to look forward to.
Join us at 2 pm ET tomorrow!
Construction of the $500 billion dollar tech city-state of the future is moving ahead.
- The futuristic megacity Neom is being built in Saudi Arabia.
- The city will be fully automated, leading in health, education and quality of life.
- It will feature an artificial moon, cloud seeding, robotic gladiators and flying taxis.
The Red Sea area where Neom will be built:
Saudi Arabia Plans Futuristic City, "Neom" (Full Promotional Video)<span style="display:block;position:relative;padding-top:56.25%;" class="rm-shortcode" data-rm-shortcode-id="c646d528d230c1bf66c75422bc4ccf6f"><iframe type="lazy-iframe" data-runner-src="https://www.youtube.com/embed/N53DzL3_BHA?rel=0" width="100%" height="auto" frameborder="0" scrolling="no" style="position:absolute;top:0;left:0;width:100%;height:100%;"></iframe></span>
Are we genetically inclined for superstition or just fearful of the truth?
- From secret societies to faked moon landings, one thing that humanity seems to have an endless supply of is conspiracy theories. In this compilation, physicist Michio Kaku, science communicator Bill Nye, psychologist Sarah Rose Cavanagh, skeptic Michael Shermer, and actor and playwright John Cameron Mitchell consider the nature of truth and why some groups believe the things they do.
- "I think there's a gene for superstition, a gene for hearsay, a gene for magic, a gene for magical thinking," argues Kaku. The theoretical physicist says that science goes against "natural thinking," and that the superstition gene persists because, one out of ten times, it actually worked and saved us.
- Other theories shared include the idea of cognitive dissonance, the dangerous power of fear to inhibit critical thinking, and Hollywood's romanticization of conspiracies. Because conspiracy theories are so diverse and multifaceted, combating them has not been an easy task for science.
A growing body of research suggests COVID-19 can cause serious neurological problems.
- The new study seeks to track the health of 50,000 people who have tested positive for COVID-19.
- The study aims to explore whether the disease causes cognitive impairment and other conditions.
- Recent research suggests that COVID-19 can, directly or indirectly, cause brain dysfunction, strokes, nerve damage and other neurological problems.
Brain images of a patient with acute demyelinating encephalomyelitis.
COVID-19 and the brain<p>A growing body of research reveals alarming neurological complications among COVID-19 patients. On Wednesday, for example, researchers from University College London published a <a href="https://academic.oup.com/brain/article/doi/10.1093/brain/awaa240/5868408" target="_blank">study</a> in the journal Brain that describes how some patients have suffered temporary brain dysfunction, strokes, nerve damage, and other neurological problems concurrent with COVID-19.</p><p>Some patients suffered brain inflammation as a result of a rare disease called acute disseminated encephalomyelitis, which can cause numbness, seizures, and confusion. One patient in the study even hallucinated monkeys and lions in her home.</p>
Photo by Mario Tama/Getty Images<p>A separate study published in the <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198407/" target="_blank">Journal of Clinical Neuroscience</a> notes that some COVID-19 patients have also suffered neurological complications like impaired consciousness and acute cerebrovascular disease. The study notes that past viruses like MERS and SARS also seemed to cause neurological problems.</p><p>A troubling finding among this growing body of research is that some patients seem to suffer neurological damage even when respiratory symptoms aren't obvious. Additionally, scientists aren't sure whether damage from the disease will be permanent.</p><p style="margin-left: 20px;">"Given that the disease has only been around for a matter of months, we might not yet know what long-term damage COVID-19 can cause," Dr. Ross Paterson, joint first author of the University College London study, said in a <a href="https://www.eurekalert.org/pub_releases/2020-07/ucl-iid070620.php" target="_blank">press release</a>. "Doctors needs to be aware of possible neurological effects, as early diagnosis can improve patient outcomes."</p><p>If you've been diagnosed with COVID-19 and want to enroll in the study, visit <a href="https://www.cambridgebrainsciences.com/studies/covid-brain-study" target="_blank">cambridgebrainsciences.com/studies/covid-brain-study</a>.</p>
Coronavirus layoffs are a glimpse into our automated future. We need to build better education opportunities now so Americans can find work in the economy of tomorrow.